NASDAQ$NRC

NRC Health · Q4 2015 earnings

Q4 2015 earnings · · Investor relations

Headline financials

Total Revenue

$26.4M

Previous: $25.1M+4.9%
EPS (adj)

$0.24

Previous: $0.17+44.1%
Net Income

$5.86M

Previous: $4.1M+42.9%
Operating Income

$7.71M

Previous: $6.42M+20.0%
Gross Profit

$15M

Previous: $14.3M+5.1%
R&D Expense

$0.00

Previous: $0.00

Revenue & EPS history

NRC · Revenue · Quarterly

$26.4M

Q4 2015+4.9%vs Q4 2014
Beat estimate in 1 of 4 quarters(25%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports

Historical avg

-0.9%

Avg return

Earnings day

-0.9%

Avg return

5 days after

-0.3%

Avg return

30 days after

54%

28 / 52 earnings

Positive

+16.1%

Q3 2025

Best reaction

-19.9%

Q4 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-0.6%+7.9%+16.0%
Q4 2025-19.9%-27.2%-35.9%
Q3 2025+16.1%+17.0%+51.2%
Q2 2025+2.1%+4.8%+6.7%
Q1 2025+7.0%+7.6%+20.2%
Q4 2024-11.9%-11.0%-22.6%
Q3 2024+2.6%-2.1%+4.5%
Q2 2024-11.7%-9.3%-7.2%
Q1 2024-15.3%-11.6%-23.7%
Q4 2023+2.2%+0.6%+1.7%
Q3 2023-1.9%-0.3%-1.1%
Q2 2023+2.2%-0.4%-2.6%
Q1 2023-8.3%-5.2%-1.2%
Q4 2022+4.8%+5.3%-1.8%
Q3 2022-13.5%-8.3%-3.5%
Q2 2022-4.1%-7.4%-12.8%
Q1 2022-5.3%-3.6%+5.0%
Q4 2021-1.5%-4.5%-4.7%
Q3 2021+6.7%+6.7%-8.1%
Q2 2021-0.8%-0.2%+1.6%
Q1 2021-10.2%-5.1%-7.0%
Q4 2020-0.7%-3.9%+0.3%
Q3 2020+1.8%-0.1%-7.8%
Q2 2020-4.1%-1.0%-3.0%
Q1 2020+4.6%+10.3%+12.7%
Q4 2019+0.3%+1.8%-36.0%
Q3 2019-0.4%+0.2%+7.5%
Q2 2019+3.0%+2.6%+1.0%
Q1 2019+7.1%+13.1%+26.5%
Q4 2018+0.6%+2.7%+0.2%
Q3 2018+3.5%+2.4%+4.8%
Q2 2018-0.3%-0.3%+2.4%
Q1 2018+7.3%+5.5%+5.4%
Q4 2017-7.4%-7.9%-9.7%
Q3 2017-10.1%-11.5%-7.7%
Q2 2017+0.9%+1.7%+9.9%
Q1 2017+0.8%-3.4%-3.0%
Q4 2016-3.0%-4.9%+0.5%
Q3 2016-4.6%-1.0%+5.2%
Q2 2016+0.3%+2.3%+2.2%
Q1 2016+2.0%
Q4 2015+0.6%
Q3 2015+1.5%
Q2 2015-2.4%
Q1 2015+1.3%
Q4 2014-0.8%
Q3 2014+0.9%
Q2 2014+3.8%
Q1 2014+3.9%
Q4 2013+5.1%
Q3 2013+1.0%
Q2 2013-1.2%
Q1 2013
Q4 2012
Q2 2010
Q3 2012
Q2 2012
Q1 2012
Q4 2011
Q1 2011
Q3 2011
Q3 2010
Q4 2009
Q2 2011
Q4 2010
Q1 2010

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro